description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CAGCCAAGAGGTGAAAGAAACTTCCATGTGTTCTATCAGCTGCTCTCTGGTGCCTCTGAAGAGCTCCTCAATAAACTTAAGCTTGAGAGGGATTTCAGCAGGTATAACTACCTGAGTCTGGATTCGGCCAAAGTGAATGGAGTGGATGATGCAGCAAATTTTAGAACCGTGCGGAATGCCATGCAGATTGTGGGCTTTATGGATCATGAAGCTGAGTCTGTCTTGGCGGTGGTGGCAGCAGTGTTGAAACTGGGGAACATTGAGTTCAAGCCCGAATCTCGAGTGAATGGTCTAGATGAAAGCAAAATCAAAGATAAAAATGAGTTAAAAGAAATTTGTGAATTGACCGGCATTGATCAATCAGTTCTAGAACGAGCATTCAGTTTCCGAACAGTTGAGGCCAAACAGGAGA
Ensembl | human accession no.
shipped in
ambient
storage temp.
−20°C
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Bhavana V Chapman et al.
BMC cancer, 15, 861-861 (2015-11-08)
Squamous cell carcinoma of the head and neck (SCCHN) remains a prevalent and devastating disease. Recently, there has been an increase in SCCHN cases that are associated with high-risk human papillomavirus (HPV) infection. The clinical characteristics of HPV-positive and HPV-negative
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU068951-50UG | 04061828385645 |
| EHU068951-20UG | 04061828608942 |